Amy Peterson
Chief Tech/Sci/R&D Officer at EXELIXIS, INC.
Net worth: 8 M $ as of 2024-03-30
Profile
Amy C.
Peterson is currently the Secretary & Director at the Conquer Cancer Foundation of the American Society of Clinical and the Chief Medical Officer & Executive Vice President at Exelixis, Inc. She previously worked as an Associate Group Medical Director at Genentech, Inc. from 2005 to 2011, Vice President-Clinical Development at Medivation LLC (California) from 2011 to 2016, Chief Medical Officer-Immuno-Oncology at BeiGene Ltd.
from 2016 to 2019, and President & Chief Operating Officer at CytomX Therapeutics, Inc. in 2022.
Dr. Peterson holds a doctorate degree from Thomas Jefferson University and an undergraduate degree from Wesleyan University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EXELIXIS, INC.
0.11% | 2024-02-22 | 322,121 ( 0.11% ) | 8 M $ | 2024-03-30 |
Amy Peterson active positions
| Companies | Position | Start |
|---|---|---|
| EXELIXIS, INC. | Chief Tech/Sci/R&D Officer | 2023-08-22 |
Conquer Cancer Foundation of the American Society of Clinical
 Conquer Cancer Foundation of the American Society of Clinical Miscellaneous Commercial ServicesCommercial Services Conquer Cancer Foundation of the American Society of Clinical Oncology operates as a non-profit organization that researches in the prevention, treatment, and cure of cancer. Its programs include health information technology platform; patient resources; online medical education; and meetings, symposia, and workshop. The company was founded in 1964 and is headquartered in Alexandria, VA. | Director/Board Member | - |
Former positions of Amy Peterson
| Companies | Position | End |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | President | 2022-09-11 |
| BEIGENE, LTD. | Chief Tech/Sci/R&D Officer | 2019-01-22 |
| MEDIVATION INC | Corporate Officer/Principal | 2016-06-30 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2010-12-31 |
Training of Amy Peterson
| Thomas Jefferson University | Doctorate Degree |
| Wesleyan University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| CYTOMX THERAPEUTICS, INC. | Health Technology |
| BEIGENE, LTD. | Health Technology |
| Private companies | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Medivation LLC engages in the development and commercialization of novel therapies to treat serious diseases for which there are limited treatment options. The company was founded by Clarence Patrick Machado and David T. Hung in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Conquer Cancer Foundation of the American Society of Clinical
Conquer Cancer Foundation of the American Society of Clinical Miscellaneous Commercial ServicesCommercial Services Conquer Cancer Foundation of the American Society of Clinical Oncology operates as a non-profit organization that researches in the prevention, treatment, and cure of cancer. Its programs include health information technology platform; patient resources; online medical education; and meetings, symposia, and workshop. The company was founded in 1964 and is headquartered in Alexandria, VA. | Commercial Services |
- Stock Market
- Insiders
- Amy Peterson
